Plus Therapeutics, Inc. (PSTV)

NASDAQ: PSTV · Real-Time Price · USD

3.650

+0.020 (0.55%)

At close: Jul 30, 2026, 4:00 PM EDT

3.556

-0.094 (-2.59%)

After-hours: Jul 30, 2026, 7:34 PM EDT

Plus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	3.02	8.76	0.08	8.55	18.12	18.4
Short-Term Investments	12.09	4.36	3.53	-	-	-
Cash & Short-Term Investments	15.11	13.11	3.61	8.55	18.12	18.4
Cash Growth	53.18%	263.67%	-57.84%	-52.79%	-1.52%	120.47%
Other Receivables	1.35	0.32	0.57	-	-	-
Total Trade Receivables	1.35	0.32	0.57	-	-	-
Other Current Assets	1.56	1.73	1.08	1.28	3.7	1.32
Total Current Assets	18.03	15.17	5.26	9.83	21.82	19.72
Net Property, Plant & Equipment	1.07	0.33	0.52	1.11	1.57	1.82
Other Intangible Assets	0.3	0.33	0.47	0.04	0.09	0.05
Goodwill	0.37	0.37	0.37	0.37	0.37	0.37
Other Long-Term Assets	0.15	0.12	0.01	0.03	0.01	0.02
Total Assets	19.92	16.33	6.63	11.39	23.87	21.98

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	6.16	5.92	11.29	6.63	10.13	4.15
Short-Term Debt	0.67	0.75	3.29	-	-	-
Current Portion of Long-Term Debt	-	-	-	3.98	1.61	1.61
Current Portion of Leases	0.06	0.06	0.04	0.12	0.11	0.11
Unearned Revenue	0.93	0.93	0.93	-	-	-
Other Current Liabilities	0.15	4.66	-	-	-	-
Total Current Liabilities	7.96	12.31	15.55	10.73	11.85	5.87
Long-Term Debt	-	-	-	-	3.79	5.01
Long-Term Leases	-	0.02	0.03	-	-	0.27
Other Long-Term Liabilities	-	-	-	-	-	0
Total Long-Term Liabilities	-	0.02	0.03	-	3.79	5.28
Total Liabilities	7.96	12.33	15.58	10.73	15.64	11.15

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.14	0.01	-	-	-
Treasury Stock	-0.5	-0.5	-0.5	-	-	-
Additional Paid-in Capital	535.27	520.22	485.02	-	-	-
Retained Earnings	-522.81	-515.87	-493.48	-	-	-
Shareholders' Equity	11.96	4	-8.95	-	-	-
Total Liabilities & Equity	19.92	16.33	6.63	10.73	15.64	11.15

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.73	0.82	3.37	4.1	5.5	6.99
Net Cash (Debt)	14.39	12.29	0.24	4.46	12.62	11.41
Net Cash Growth	46.42%	5043.52%	-94.64%	-64.66%	10.60%	738.75%
Net Cash Per Share	2.24	3.95	0.78	35.48	180.19	353.84
Book Value	11.96	4	-8.95	0	0	0
Book Value Per Share	1.86	1.28	-29.05	-	-	-
Tangible Book Value	11.29	3.29	-9.79	-0.41	-0.47	-0.42
Tangible Book Value Per Share	1.75	1.06	-31.78	-3.30	-6.66	-13.12

SEC Filings: 10-K · 10-Q